Movement Alert|Twist Bioscience Corp Rises 5.24% in Regular Trading, Trading at $131.24

Market Focus
09/09

On September 8, Twist Bioscience Corp rose 5.24% in regular trading, trading at $131.24 USD/share, with Turnover of $117 million.

Within the Biotechnology sector where Twist Bioscience Corp belongs, individual stocks showed mixed performance. Among individual stocks, Roivant Sciences Ltd. up 20.27%, Amgen down 9.52%, Ionis Pharmaceuticals down 3.06%, AbbVie down 2.28%, Moderna, Inc. down 1.04%.

Twist Bioscience Corp engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments, oligo pools, NGS tools, and antibody optimization solutions used across therapeutics, diagnostics, food and agriculture, data storage, and academic research. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10